EXAGEN INC. (XGN)

↓ Download CSV

CIK 0001274737 · Nasdaq · Services-Medical Laboratories

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, EXAGEN INC. reported revenue of $66.58M, up 19.7% from the prior year. The company ran a net loss, with a net margin of -30.0% and a gross margin of 58.3%. It held $58.02M in total assets against $40.57M in total liabilities.

Key ratios (FY2025)

58.3%
Gross margin
-21.1%
Operating margin
-30.0%
Net margin
-114.3%
Return on equity
+19.7%
Revenue growth (YoY)
Metric (FY)202520242023202220212020201920182017
Revenue$66.58M$55.64M$52.55M$45.56M$48.30M$41.98M$40.39M$32.44M
Cost of Revenue$27.78M$22.53M$23.09M$24.21M$20.59M$16.56M$18.81M$15.38M
Gross Profit$38.80M$33.11M$29.46M
Operating Income-$14.07M-$13.64M-$22.84M-$46.05M-$24.07M-$15.19M-$9.30M-$4.88M
Net Income-$19.95M-$15.12M-$23.69M-$47.39M-$26.85M-$16.69M-$12.04M-$8.01M
EPS (Diluted)$-0.93$-0.83$-1.34$-2.77$-1.68$-1.32
Total Assets$58.02M$44.69M$56.94M$86.22M$123.44M$78.38M$88.31M$28.89M
Total Liabilities$40.57M$35.15M$34.25M$43.76M$38.51M$36.54M$32.65M$35.62M
Shareholders' Equity$17.45M$9.54M$22.69M$42.46M$84.94M$41.84M$55.66M-$111.97M-$96.68M
Cash & Equivalents$32.22M$22.04M$36.49M$62.39M$99.44M$57.45M$72.08M$13.16M
Operating Cash Flow-$13.62M-$13.28M-$14.46M-$32.14M-$20.27M-$14.08M-$9.71M-$9.30M
Capital Expenditures$641.0K$515.0K$828.0K$4.32M$2.37M$455.0K$403.0K$199.0K
Shares Outstanding22.91M17.64M17.05M16.55M16.16M12.65M12.56M63.0K